We therefore hypothesise that the reduction in VEGF‐C and likely VEGF‐D and the subsequent reduction in lymphangiogenesis is due to aspirin's effect on the tumour microenvironment (Figure 6). This evidence concerns the gene VEGFD and neoplasm.